Sign inJoin waitlistJoin the waitlist

Armeen Mahvash

Professor · University of Texas M D Anderson Cancer Center

Credentials: · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present
The University of Texas Medical School at Houston
Present

The University of Texas Medical School at Houston
2005–2006
Interventional Radiology
2000–2005
Preliminary or Transitional Year
1999–2000
Baylor College of Medicine
1995–1999
University of Texas at Austin
1991

Research

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
The Lancet Oncology · 2017 · 315 citations
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small…
Journal of the American College of Surgeons · 2013 · 254 citations
International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 192 citations

Bruno Odisio
29 papers
Ahmed Kaseb
18 papers
Mohamed Abdelsalam
17 papers · 4 as a fellow
Rony Avritscher
17 papers
Jean-Nicolas Vauthey
16 papers
Ravi Murthy
16 papers
Steven Huang
15 papers · 8 as a resident
Sanjay Gupta
14 papers
Joshua Kuban
12 papers · 1 as a fellow
MW
Michael Wallace
12 papers
James Yao
11 papers
Alda Tam
10 papers

Clinical trials

TriNav Infusion System for the Evaluation of Fidelity Between 99mTc-MAA and Y90-Microspheres Hepatic Distribution for Dosimetry Treatment Planning
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2023–2027
Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients
Principal investigator · Active not recruiting
Sirtex Medical
2021–2026
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
Principal investigator · Active not recruiting
M.D. Anderson Cancer Center
2019–2026
Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
Principal investigator · Active not recruiting · Phase 1
M.D. Anderson Cancer Center
2017–2027